Viewing Study NCT00648050


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-01 @ 3:26 AM
Study NCT ID: NCT00648050
Status: COMPLETED
Last Update Posted: 2024-04-24
First Post: 2008-03-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to VerelanĀ® PM Extended-Release Capsules 300 mg
Sponsor: Mylan Pharmaceuticals Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module